NEWS News Release
-
Press Release
幹細胞培養上清液による治療薬開発を目指す創薬ベンチャーの株式会社U-Factorが、慶應義塾大学医学部と共同で眼科疾患の基礎研究の第2弾を開始
-
Press Release
U-Factor Co., Ltd., a Drug Discovery Venture Focused on Developing Therapeutics Using Stem Cell Culture Supernatant, Launches Second Phase of Ophthalmic Disease Research in Collaboration with Keio University School of Medicine
-
Press Release
U-Factor®液による治療薬開発を目指す株式会社U-Factorが東京女子医科大学と共同研究契約を締結
-
Press Release
U-Factor Co., Ltd. Signs Joint Research Agreement with Tokyo Women’s Medical University for the Development of Therapeutics Using U-Factor solution
-
Press Release
Announcement of the Commencement of a Specific Clinical Study for ALS
-
Press Release
ALS に対する特定臨床研究開始のお知らせ
-
Press Release
U-Factor Co., Ltd. Signs Agreement with AIST Solutions
-
Press Release
AIST Solutionsと契約締結
-
Press Release
Filed a patent for a dry eye treatment in collaboration with Keio University
-
Press Release
慶應大と共同でドライアイ治療薬特許出願